colgat report friday open past
week consensu ad ep stand
estim still may low impli neg
cost leverag strike us unlik ep
assum profit grow earn power similar
 gs consid acceler sale promot
time low commod price
pantri build stretch probabl vanish
worri much consum demand colgat
product afford necess page well
recessionari europ argu reason cl
outperform look compel april
cl achil heel histor macro latin
america time differ brazil
thu far mitig risk ceo wallac know
region well crisi could consum
revalu cleanli trust core tenet colgat
org sale expect albeit reflect pantry-build
expect strength across europ latin america
 america sale could base iri data
show consum take-away grow lift pre-
lockdown sale march time shipment procter
kimberli report similar shipment retail growth gap
retail restock mean shipment ahead
retail sale look past pantri load one question
whether colgat see stronger demand page
earli indic ye thru april sale home
person cleans product half colgate-u sale
still grow brand softsoap palmol
ajax well-establish value-pr necess
hold well consum mind moni
past pantry-load oral care hold well
consum arent brush frequent colgat
toothpaste/ brush lowest entri price
pleas see analyst certif import disclosur page report evercor isi affili seek busi
compani cover research report investor awar firm may conflict interest could affect
object report investor consid report singl factor make invest decis
loss oral care reflect difficulti premium
sensodyn retail averag colgat toothpast us cl
technolog gap therapeut oral care vs gsk doesnt seem
materi sensodyn thrive recessionari environ
premium-pr hill pet food also advantag busi
squar focus health ii align gate keeper vet specialti
retail iii e-commerc plu dtc platform lend on-line
colgat achil heel alway latin america horrid macro
brazil enter crisi mend page pharmaci
sale rebound indic trade-up devalu silver
line mexico becom colgat largest latin america
mexico colgat stronghold
price power latin america weve argu count
much price doesnt seem need yet
entry-point price make colgat portfolio defens
countri tradit trade fragment remain domin
colgat high market share say brazil india account one-third
compani global sale market wed expect colgat take
price transact cost requir
colgat hold even gain market share downturn
caveat neg mix colgat case neg mix would weigh
report volum growth recal colgat doesnt report volum
volume/ mix financi report keep firm sale forc
incentiv drive gross margin expans
pantri load march
sale colgat america
colgat america baselin sale growth past year
sourc colgat file iri muloc all-u track channel channel data evercor isi analysi
vari outcom march quarter
slightli
vari impact categori channel beauti discretionari
household potenti increas use frequenc
compani sale
look ahead impact differ stage pl next concern
acceler shift e-commerc
yet come anticip
trade
restaur cut
get close neutral
privat label meaning factor
cl categori
privat label share hpc categori
colgat categori red
cl product valu price
updat imf world econom outlook april updat
spike preced great recess commod came stabl covid crisi
arriv target per cl share base rel intrins valuat methodolog
discount cash flow model point fair valu per share use wacc
growth termin valu base project ep growth
target impli forward price-to-earnings premium today xlp stapl sector
pt impli regress mean share trade rang re-rat cl share
histor averag predic convict health global oral care market
colgat capac recalibr portfolio busi model restart market share gain
widen leadership believ challeng pressur cl valuat structur
expens deal street fear like manag restructur save
back-end load cl afford higher reinvest power
there limit downsid risk given cl trade one standard deviat trade averag vs stapl
sector model assum improv macro environ brazil key profit center firm colgat
success diversifi portfolio natur therapeut oral care howev greatest risk stem increas
competit busi outsid oral care home care person care categori colgat lack financi
incent reinvest structur part cl person care busi becom less attract colgat person care
busi compos region brand miss structur premium categori
articl articl
time dissemin april pm et
analyst yutong zhou javier escalant robert ottenstein primarili respons prepar research report attest
follow view opinion render research report reflect person view subject compani
issuer part research analyst compens directli relat specif recommend view
research report
